investorscraft@gmail.com

Intrinsic ValueClariant AG (0QJS.L)

Previous Close£7.15
Intrinsic Value
Upside potential
Previous Close
£7.15

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Clariant AG is a global specialty chemicals company with a diversified portfolio spanning three core segments: Care Chemicals, Catalysis, and Natural Resources. The company serves a broad range of industries, including plastics, coatings, petrochemicals, oil and gas, mining, and consumer applications, leveraging its expertise in flame retardants, performance additives, catalysts, and advanced surface solutions. Clariant’s revenue model is built on high-value, application-specific chemical solutions that cater to niche industrial and consumer markets, often requiring technical expertise and regulatory compliance. The company maintains a competitive edge through innovation, particularly in sustainable chemistry, such as its sunliquid technology for bioethanol production and Veritrax for intelligent chemical management in oilfields. Operating in a fragmented but highly specialized sector, Clariant differentiates itself through R&D-driven product development and strategic collaborations, positioning it as a key player in sustainability-focused chemical solutions. Its global footprint and diversified end-market exposure provide resilience against cyclical downturns in individual industries.

Revenue Profitability And Efficiency

In FY 2023, Clariant reported revenue of CHF 4.38 billion, with net income of CHF 134 million, reflecting a net margin of approximately 3.1%. The company generated CHF 421 million in operating cash flow, demonstrating solid cash conversion despite moderate profitability. Capital expenditures totaled CHF 204 million, indicating ongoing investments in operational capabilities and innovation. The diluted EPS of CHF 0.51 underscores the challenges of margin compression in the specialty chemicals sector.

Earnings Power And Capital Efficiency

Clariant’s earnings power is supported by its diversified product portfolio and focus on high-margin specialty applications. However, the modest net income relative to revenue suggests operational inefficiencies or pricing pressures in certain segments. The company’s ability to generate positive operating cash flow highlights its working capital management, though capital expenditures remain a significant outflow, reflecting its commitment to long-term growth initiatives.

Balance Sheet And Financial Health

Clariant’s balance sheet shows CHF 488 million in cash and equivalents against total debt of CHF 1.23 billion, indicating a manageable leverage position. The debt-to-equity ratio appears reasonable for a capital-intensive industry, though liquidity could be tighter given the cyclical nature of chemical demand. The company’s financial health is stable, with sufficient liquidity to meet near-term obligations and fund strategic investments.

Growth Trends And Dividend Policy

Clariant’s growth is driven by innovation in sustainable chemistry and expansion in emerging markets. The company paid a dividend of CHF 0.42 per share in FY 2023, reflecting a commitment to shareholder returns despite modest earnings. Future growth may hinge on scaling its bio-based solutions and optimizing its portfolio for higher-margin segments, though macroeconomic headwinds could temper near-term performance.

Valuation And Market Expectations

With a market capitalization of approximately CHF 5.87 billion, Clariant trades at a valuation reflective of its niche positioning and growth potential in sustainable chemicals. The beta of 0.602 suggests lower volatility compared to the broader market, aligning with its defensive industry characteristics. Investor expectations likely center on margin improvement and successful execution of its sustainability-focused strategy.

Strategic Advantages And Outlook

Clariant’s strategic advantages lie in its technical expertise, diversified end-market exposure, and focus on sustainable solutions. The outlook is cautiously optimistic, with growth opportunities in bio-based chemicals and digital solutions like Veritrax. However, competitive pressures and raw material cost volatility remain key risks. The company’s ability to innovate and adapt to regulatory trends will be critical in maintaining its market position.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount